Newsfile Corp
10 Oct 2026, 18:11 UTC · 1h ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
Impact · against what's priced in
Unicycive faces negative pressure as a class action lawsuit highlights significant regulatory and manufacturing risks that could delay the approval of oxylanthanum carbonate. Gildan Activewear is similarly impacted by an investigation into a potential securities class action.
- UNCY−0.60
No priced-in read yet





